New devices for TAVI: Technologies and initial clinical experiences

Maurizio Taramasso, Alberto Pozzoli, Azeem Latib, Giovanni La Canna, Antonio Colombo, Francesco Maisano, Ottavio Alfieri

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Treatment of aortic stenosis in high-risk surgical patients has been modified in the past 10 years owing to the introduction of transcatheter aortic valve implantation (TAVI). Several issues affecting outcomes with implantation of the first-generation TAVI devices remain unresolved, including haemorrhagic and vascular complications, neurological events, rhythm disturbances, and paravalvular leakage. Further technological improvements are, therefore, required before the indications for TAVI can be extended to young and low-risk patients with aortic stenosis. Many new-generation TAVI devices are currently in the early stages of clinical evaluation. Modifications in the new devices include the ability to reposition the valve before final deployment, features to reduce paravalvular leakage, and the introduction of low-profile delivery systems. The aim of this Review is to provide an overview of the new-generation transcatheter valvular technologies, including initial clinical reports.

Original languageEnglish
Pages (from-to)157-167
Number of pages11
JournalNature Reviews Cardiology
Volume11
Issue number3
DOIs
Publication statusPublished - Mar 2014

Fingerprint

Technology
Equipment and Supplies
Aortic Valve Stenosis
Blood Vessels
Transcatheter Aortic Valve Replacement
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

New devices for TAVI : Technologies and initial clinical experiences. / Taramasso, Maurizio; Pozzoli, Alberto; Latib, Azeem; La Canna, Giovanni; Colombo, Antonio; Maisano, Francesco; Alfieri, Ottavio.

In: Nature Reviews Cardiology, Vol. 11, No. 3, 03.2014, p. 157-167.

Research output: Contribution to journalArticle

Taramasso, Maurizio ; Pozzoli, Alberto ; Latib, Azeem ; La Canna, Giovanni ; Colombo, Antonio ; Maisano, Francesco ; Alfieri, Ottavio. / New devices for TAVI : Technologies and initial clinical experiences. In: Nature Reviews Cardiology. 2014 ; Vol. 11, No. 3. pp. 157-167.
@article{cb3323e49763435cbb27cb2cc48612b1,
title = "New devices for TAVI: Technologies and initial clinical experiences",
abstract = "Treatment of aortic stenosis in high-risk surgical patients has been modified in the past 10 years owing to the introduction of transcatheter aortic valve implantation (TAVI). Several issues affecting outcomes with implantation of the first-generation TAVI devices remain unresolved, including haemorrhagic and vascular complications, neurological events, rhythm disturbances, and paravalvular leakage. Further technological improvements are, therefore, required before the indications for TAVI can be extended to young and low-risk patients with aortic stenosis. Many new-generation TAVI devices are currently in the early stages of clinical evaluation. Modifications in the new devices include the ability to reposition the valve before final deployment, features to reduce paravalvular leakage, and the introduction of low-profile delivery systems. The aim of this Review is to provide an overview of the new-generation transcatheter valvular technologies, including initial clinical reports.",
author = "Maurizio Taramasso and Alberto Pozzoli and Azeem Latib and {La Canna}, Giovanni and Antonio Colombo and Francesco Maisano and Ottavio Alfieri",
year = "2014",
month = "3",
doi = "10.1038/nrcardio.2013.221",
language = "English",
volume = "11",
pages = "157--167",
journal = "Nature Reviews Cardiology",
issn = "1759-5002",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - New devices for TAVI

T2 - Technologies and initial clinical experiences

AU - Taramasso, Maurizio

AU - Pozzoli, Alberto

AU - Latib, Azeem

AU - La Canna, Giovanni

AU - Colombo, Antonio

AU - Maisano, Francesco

AU - Alfieri, Ottavio

PY - 2014/3

Y1 - 2014/3

N2 - Treatment of aortic stenosis in high-risk surgical patients has been modified in the past 10 years owing to the introduction of transcatheter aortic valve implantation (TAVI). Several issues affecting outcomes with implantation of the first-generation TAVI devices remain unresolved, including haemorrhagic and vascular complications, neurological events, rhythm disturbances, and paravalvular leakage. Further technological improvements are, therefore, required before the indications for TAVI can be extended to young and low-risk patients with aortic stenosis. Many new-generation TAVI devices are currently in the early stages of clinical evaluation. Modifications in the new devices include the ability to reposition the valve before final deployment, features to reduce paravalvular leakage, and the introduction of low-profile delivery systems. The aim of this Review is to provide an overview of the new-generation transcatheter valvular technologies, including initial clinical reports.

AB - Treatment of aortic stenosis in high-risk surgical patients has been modified in the past 10 years owing to the introduction of transcatheter aortic valve implantation (TAVI). Several issues affecting outcomes with implantation of the first-generation TAVI devices remain unresolved, including haemorrhagic and vascular complications, neurological events, rhythm disturbances, and paravalvular leakage. Further technological improvements are, therefore, required before the indications for TAVI can be extended to young and low-risk patients with aortic stenosis. Many new-generation TAVI devices are currently in the early stages of clinical evaluation. Modifications in the new devices include the ability to reposition the valve before final deployment, features to reduce paravalvular leakage, and the introduction of low-profile delivery systems. The aim of this Review is to provide an overview of the new-generation transcatheter valvular technologies, including initial clinical reports.

UR - http://www.scopus.com/inward/record.url?scp=84896736201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896736201&partnerID=8YFLogxK

U2 - 10.1038/nrcardio.2013.221

DO - 10.1038/nrcardio.2013.221

M3 - Article

C2 - 24445486

AN - SCOPUS:84896736201

VL - 11

SP - 157

EP - 167

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

SN - 1759-5002

IS - 3

ER -